PTGX

Protagonist Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.32 -5.22% 23.99 20:00:00
Open Price Low Price High Price Close Price Prev Close
25.29 23.95 26.007 23.99 25.31
more quote information »

Recent News

Date Time Source Heading
2/25/20217:00IHNWFeaturedRoofstock Review: The Gateway to Real Estate Investing for Millennials
2/25/20218:45IHNWFeaturedCannabix Technologies Develops Version 3.0 of THC Breath Analyzer Device
2/16/202114:23EDGARStatement of Ownership (sc 13g)
2/16/202107:00PRNUSProtagonist Therapeutics to Participate in the SVB Leerink..
2/16/202106:26EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202106:22EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202118:56EDGARStatement of Changes in Beneficial Ownership (4)
2/12/202109:37EDGARAmended Statement of Ownership (sc 13g/a)
2/08/202110:33EDGARAmended Statement of Ownership (sc 13g/a)
2/02/202115:16EDGARStatement of Ownership (sc 13g)
2/02/202106:01EDGARAmended Statement of Ownership (sc 13g/a)
1/29/202118:22PRNUSProtagonist Therapeutics Reports Granting of Inducement..
1/13/202113:32TRMN3 Top Biotech Stocks for 2021
1/04/202107:00PRNUSProtagonist Therapeutics to Present at the 39th Annual J.P...
12/16/202007:30PRNUSProtagonist Therapeutics Announces First Subject Dosed in..
12/15/202016:30PRNUSProtagonist Therapeutics, Inc. Announces Closing of $115..
12/14/202006:01EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/10/202023:10PRNUSProtagonist Therapeutics, Inc. Announces Pricing of $100..
12/10/202007:30PRNUSProtagonist Therapeutics, Inc. Announces Proposed Public..
12/10/202007:20EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
12/07/202010:00PRNUSProtagonist Announces Results of Large-Scale Analysis of..
12/06/202014:45PRNUSProtagonist Announces Updated Phase 2 Data Presented at ASH..
12/02/202007:00PRNUSProtagonist's Hepcidin Mimetic Candidate PTG-300 Receives..
12/01/202016:30PRNUSProtagonist Therapeutics Reports Granting of Inducement..
11/30/202007:00PRNUSProtagonist to Host Conference Call and Webcast to Provide a..
11/25/202007:00PRNUSProtagonist Therapeutics to Present at the Virtual Piper..
11/11/202016:30PRNUSProtagonist Therapeutics to Participate in the Jefferies..
11/04/202017:22EDGARQuarterly Report (10-q)
11/04/202017:13EDGARCurrent Report Filing (8-k)
11/04/202016:54PRNUSProtagonist Therapeutics Reports Third Quarter Financial..
11/04/202010:20PRNUSProtagonist Therapeutics to Present Updated Clinical Data..
10/30/202018:27PRNUSProtagonist Therapeutics Reports Granting of Inducement..
10/29/202016:30PRNUSProtagonist Therapeutics Announces Advancement of Oral IL-23..
10/21/202007:00PRNUSProtagonist Therapeutics Receives Orphan Drug Designation..
10/02/202017:14EDGARAmended Current Report Filing (8-k/a)
9/17/202016:30PRNUSProtagonist Therapeutics to Participate in the Jefferies..
9/15/202016:48PRNUSProtagonist Therapeutics Reports Granting of Inducement..
9/11/202016:33EDGARCurrent Report Filing (8-k)
9/10/202016:30PRNUSProtagonist Therapeutics to Participate in the H.C...
9/02/202016:30PRNUSProtagonist Therapeutics to Host PTG-300 Opportunity Update..
8/18/202017:34EDGARStatement of Changes in Beneficial Ownership (4)
8/18/202017:05EDGARInitial Statement of Beneficial Ownership (3)
8/13/202016:35EDGARCurrent Report Filing (8-k)
8/13/202016:30PRNUSProtagonist Appoints Sarah O'Dowd to Board of Directors
8/12/202017:39EDGARStatement of Changes in Beneficial Ownership (4)
8/06/202016:09EDGARCurrent Report Filing (8-k)
8/06/202016:01PRNUSProtagonist Therapeutics Reports Second Quarter Financial..
6/17/202023:07PRNUSHepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug..
6/16/202018:05PRNUSProtagonist Therapeutics to Participate in the BMO..
6/09/202016:33EDGARAmended Statement of Ownership (sc 13g/a)
6/08/202016:05EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/04/202007:00PRNUSProtagonist Therapeutics to Present at the 25th European..
See more news about this stock »


Your Recent History
NASDAQ
PTGX
Protagonis..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.